Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sotera Health (SHC) EPS (Weighted Average and Diluted) (2020 - 2026)

Sotera Health has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at $0.12 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 140.0% year-over-year to $0.12; the TTM value through Dec 2025 reached $0.27, up 68.75%, while the annual FY2025 figure was $0.27, 68.75% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.12 at Sotera Health, down from $0.17 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.17 in Q3 2025 and troughed at -$1.14 in Q4 2022.
  • A 5-year average of $0.01 and a median of $0.07 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 3594.75% in 2021 and later plummeted 1050.0% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.12 in 2021, then crashed by 1050.0% to -$1.14 in 2022, then skyrocketed by 112.28% to $0.14 in 2023, then crashed by 64.29% to $0.05 in 2024, then skyrocketed by 140.0% to $0.12 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SHC at $0.12 in Q4 2025, $0.17 in Q3 2025, and $0.03 in Q2 2025.